LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
LMPR0106040004
|
3,11-diketofusidic acid
|
(-)-16beta-acetoxy-3alpha,11alpha-dioxofusida-17(20)Z,24-diene-21-oic acid
|
|
C31H44O6
|
512.313790
|
LMPR0106040005
|
3-ketofusidic acid
|
(-)-16beta-acetoxy-3-oxo-11alpha-hydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C31H46O6
|
514.329440
|
LMPR0106040006
|
Viridominic acid A
|
6alpha,16beta-diacetoxy-11-oxo-3alpha,7beta-dihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C33H48O9
|
588.329835
|
LMPR0106040007
|
Viridominic acid B
|
6alpha,16beta-diacetoxy-11-oxo-3alpha,7beta,12alpha-trihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C33H48O10
|
604.324750
|
LMPR0106040008
|
Viridominic acid C
|
6alpha,16beta-diacetoxy-3alpha,7beta,11beta-trihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C33H50O9
|
590.345485
|
LMPR0106040009
|
Cephalosporin P1
|
6alpha,16beta-diacetoxy-3alpha,7beta-dihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C33H50O8
|
574.350570
|
LMPR0106040010
|
Isocephalosporin P1
|
7beta,16beta-diacetoxy-3alpha,6alpha-dihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C33H50O8
|
574.350570
|
LMPR0106040011
|
Monodesacetyl cephalosporin P1
|
16beta-acetoxy-3alpha,7beta,6alpha-trihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C31H48O7
|
532.340005
|
LMPR0106040012
|
11-ketofusidic acid
|
(-)-16beta-acetoxy-11-oxo-3alphahydroxy-fusida-17(20)Z,24-diene-21-oic acid
|
|
C31H46O6
|
514.329440
|
LMPR0106040013
|
3-epifusidic acid
|
(-)-16beta-acetoxy-3beta,11alpha-dihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C31H48O6
|
516.345090
|
LMPR0106040014
|
11-epifusidic acid
|
(-)-16beta-acetoxy-3alpha,11beta-dihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C31H48O6
|
516.345090
|
LMPR0106040015
|
9,11-Anhydro Fusidic Acid
|
(-)-16beta-acetoxy-3alpha-hydroxyfusida-9(11),17(20)Z,24-triene-21-oic acid
|
|
C31H46O5
|
498.334525
|
LMPR0106040016
|
12-hydroxy-9,11-Anhydro Fusidic Acid
|
(-)-16beta-acetoxy-3alpha,12-dihydroxyfusida-9(11),17(20)Z,24-triene-21-oic acid
|
|
C31H46O6
|
514.329440
|
LMPR0106040017
|
7,8-dehydropseudofusidic acid
|
(-)-16beta-acetoxy-3alpha,12alpha-dihydroxyfusida-7,17(20),24-triene-21-oic acid
|
|
C30H44O6
|
500.313790
|
LMPR0106090003
|
Meliasanine A
|
(5R,9R,10R,13S,14S,16S,17S,20S)-3,6-dione-16-hydroxy-tirucalla-7,24-diene
|
|
C30H46O3
|
454.344695
|
LMPR0106090004
|
Meliasanine B
|
(3R,5R,9R,10R,13S,14S,16S,17S,20S) methyl 6-oxo-3,16-dihydroxy-tirucalla-7,24-dien-20-oate
|
|
C31H48O5
|
500.350175
|
LMPR0106090005
|
Meliasanine C
|
(3S,5R,9R,10R,13S,14S,16S,17S,20S) methyl 6-oxo-3,16-dihydroxy-tirucalla-7,24-dien-20-oate
|
|
C31H48O5
|
500.350175
|
LMPR0106040018
|
Alisol A
|
11beta,23S,24R,25-tetrahydroxy-dammar-13(17)-en-3-one
|
|
C30H50O5
|
490.365825
|
LMPR0106150065
|
Escin 1a
|
21-tigoyl-22-acetyl-protoaescigenin 3-O[beta-D-glucopyranosyl (1-2)][beta-D-glucopyranosyl (1-4)]-beta-D-glucopyranosiduronic acid
|
|
C55H86O24
|
1130.550910
|
LMPR0106150066
|
Escin 1b
|
21-angeloyl-22-acetyl-protoaescigenin 3-O[beta-D-glucopyranosyl (1-2)][beta-D-glucopyranosyl (1-4)]-beta-D-glucopyranosiduronic acid
|
|
C55H86O24
|
1130.550910
|
LMPR0106150067
|
Escin IIa
|
21-tigloyl-22-acetyl-protoaescigenin 3-O[beta-D-xylopyranosyl (1-2)][beta-D-glucopyranosyl (1-4)]-beta-D-glucopyranosiduronic acid
|
|
C54H84O23
|
1100.540345
|
LMPR0106150068
|
Escin IIb
|
21-angeloyl-22-acetyl-protoaescigenin 3-O[beta-D-xylopyranosyl (1-2)][beta-D-glucopyranosyl (1-4)]-beta-D-glucopyranosiduronic acid
|
|
C54H84O23
|
1100.540345
|
LMPR0106150069
|
Escin IIIa
|
21-angeloyl-22-acetyl-barringtogenol 3-O[beta-D-glucopyranosyl (1-2)][beta-D-glucopyranosyl (1-4)]-beta-D-glucopyranosiduronic acid
|
|
C55H86O23
|
1114.555995
|
LMPR0106150070
|
Barringtogenol C
|
Olean-12-ene-3beta,16alpha,21beta,22alpha,28-pentol
|
|
C30H50O5
|
490.365825
|